Literature DB >> 12468012

Blood-brain barrier, brain metabolism and cerebral blood flow.

O B Paulson1.   

Abstract

For optimal function of the brain with its meticulous operations, an adequate and constant micro environment seems to be a prerequisite. This is secured by the blood-brain barrier which is impermeable to hydrophilic substances, with notable exceptions such as glucose, which cross the barrier by a mechanism of facilitated diffusion. A constant micro environment is further secured by the blood flow which is balanced to the metabolic demand of the cerebral tissue and which also contributes to the maintenance of a constant pH. During activation, blood flow and glucose consumption increase more than oxygen consumption in activated areas of the brain. The flow increase forms the physiological basis for measurement and mapping of functional activation using positron emission tomography and the changes in the metabolic pattern which has been called uncoupling of flow and oxygen metabolism is the basis for such measurements using functional magnetic resonance imaging.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12468012     DOI: 10.1016/s0924-977x(02)00098-6

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  24 in total

Review 1.  Functional expression and localization of P-glycoprotein in the central nervous system: relevance to the pathogenesis and treatment of neurological disorders.

Authors:  Gloria Lee; Reina Bendayan
Journal:  Pharm Res       Date:  2004-08       Impact factor: 4.200

2.  Effect of electrical forepaw stimulation on capillary transit-time heterogeneity (CTH).

Authors:  Eugenio Gutiérrez-Jiménez; Changsi Cai; Irene Klærke Mikkelsen; Peter Mondrup Rasmussen; Hugo Angleys; Mads Merrild; Kim Mouridsen; Sune Nørhøj Jespersen; Jonghwan Lee; Nina Kerting Iversen; Sava Sakadzic; Leif Østergaard
Journal:  J Cereb Blood Flow Metab       Date:  2016-02-08       Impact factor: 6.200

3.  Cortical laminar necrosis related to prolonged focal status epilepticus.

Authors:  A Donaire; M Carreno; B Gómez; P Fossas; N Bargalló; R Agudo; M Falip; X Setoaín; T Boget; T Raspall; V Obach; J Rumiá
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-01       Impact factor: 10.154

4.  Collagen-based brain microvasculature model in vitro using three-dimensional printed template.

Authors:  Jeong Ah Kim; Hong Nam Kim; Sun-Kyoung Im; Seok Chung; Ji Yoon Kang; Nakwon Choi
Journal:  Biomicrofluidics       Date:  2015-04-15       Impact factor: 2.800

5.  NMR Metabolomics Analysis of Parkinson's Disease.

Authors:  Shulei Lei; Robert Powers
Journal:  Curr Metabolomics       Date:  2013

Review 6.  Cerebrovascular Dysfunction in Preeclamptic Pregnancies.

Authors:  Erica Shields Hammer; Marilyn J Cipolla
Journal:  Curr Hypertens Rep       Date:  2015-08       Impact factor: 5.369

7.  A two-stage approach for measuring vascular water exchange and arterial transit time by diffusion-weighted perfusion MRI.

Authors:  Keith S St Lawrence; Daron Owen; Danny J J Wang
Journal:  Magn Reson Med       Date:  2011-08-19       Impact factor: 4.668

Review 8.  In vivo brain imaging of human exposure to nicotine and tobacco.

Authors:  Anil Sharma; Arthur L Brody
Journal:  Handb Exp Pharmacol       Date:  2009

9.  Different cyclical intermittent hypoxia severities have different effects on hippocampal microvasculature.

Authors:  Diane C Lim; Daniel C Brady; Rajath Soans; Emily Y Kim; Laise Valverde; Brendan T Keenan; Xiaofeng Guo; Woo Young Kim; Min Jeong Park; Raymond Galante; James A Shackleford; Allan I Pack
Journal:  J Appl Physiol (1985)       Date:  2016-04-28

10.  Ventromedial hypothalamic nitric oxide production is necessary for hypoglycemia detection and counterregulation.

Authors:  Xavier Fioramonti; Nicolas Marsollier; Zhentao Song; Kurt A Fakira; Reema M Patel; Stacey Brown; Thibaut Duparc; Arnaldo Pica-Mendez; Nicole M Sanders; Claude Knauf; Philippe Valet; Rory J McCrimmon; Annie Beuve; Christophe Magnan; Vanessa H Routh
Journal:  Diabetes       Date:  2009-11-23       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.